Clinical trial
A Randomized, Placebo-controlled, Double-blind, Multi-center Study of the Safety and Efficacy of Niyad in Patients Undergoing Continuous Renal Replacement Therapy (CRRT) Who Cannot Tolerate Heparin or Are at a Higher Risk for Bleeding
NCT06150742 is registered in ClinicalTrials.gov with Talphera, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled, Double-blind, Multi-center Study of the Safety and Efficacy of Niyad in Patients Undergoing Continuous Renal Replacement Therapy (CRRT) Who Cannot Tolerate Heparin or Are at a Higher Risk for Bleeding
- Lead sponsor
- Talphera, Inc
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 15, 2024
- Completion date
- December 31, 2025
- Enrollment
- 70 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.